BACKGROUND: Diffuse peritonitis is an acute abdominal condition characterized by high mortality. The main treatment modality is surgery, requiring a subsequent prolonged hospital stay. These patients are, among other things, at risk of developing hospital-acquired pneumonia (HAP), which considerably worsens their treatment outcomes. This study aimed to extend the existing knowledge by providing more detailed microbiological characteristics of complicating HAP in patients with secondary peritonitis, including the identification of isolated bacterial pathogens and their potential sources. METHODS: The 2015-2019 retrospective study comprised all patients with an intraoperatively confirmed diagnosis of secondary diffuse peritonitis who were classified in accordance with the quick Sepsis Related Organ Failure Assessment scoring system. RESULTS: HAP developed in 15% of patients. The 90-day mortality rates were 53% and 24% in patients with and without HAP; respectively. The most frequent pathogens responsible for HAP were Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae complex and Enterococcus faecalis. Multidrug resistance to antibiotics was found in 38% of bacterial pathogens. Clonal spread of these bacterial pathogens among patients was not detected. Rather, the endogenous characteristic of HAP was confirmed. CONCLUSIONS: The initial antibiotic therapy of complicating HAP in patients with secondary peritonitis must be effective mainly against enterobacteria, including strains with the production of ESBL and AmpC beta-lactamases, Pseudomonas aeruginosa and Enterococcus faecalis. The study further highlighted the importance of monitoring the respiratory tract bacterial microflora in patients with secondary peritonitis. The results should be used for initial antibiotic treatment of complicating HAP instances.

Department of Anesthesiology Resuscitation and Intensive Care University Hospital Olomouc Zdravotníků 248 7 77900 Olomouc Czech Republic

Department of Microbiology Faculty of Medicine and Dentistry Palacký University Olomouc Hněvotínská 976 3 77515 Olomouc Czech Republic

Department of Surgery 1 Faculty of Medicine and Dentistry Palacký University Olomouc Hněvotínská 976 3 77515 Olomouc Czech Republic

Zobrazit více v PubMed

Skipworth R., Fearon K. Acute abdomen: Peritonitis. Surgery. 2008;26:98–101. doi: 10.1016/j.mpsur.2008.01.004. DOI

Lopez N., Kobayashi L., Coimbra R. A Comprehensive review of abdominal infections. World J. Emerg. Surg. 2011;6:7. doi: 10.1186/1749-7922-6-7. PubMed DOI PMC

Clements T.W., Tolonen M., Ball C.G., Kirkpatrick A.W. Secondary Peritonitis and Intra-Abdominal Sepsis: An Increasingly Global Disease in Search of Better Systemic Therapies. Scand. J. Surg. 2021;110:139–149. doi: 10.1177/1457496920984078. PubMed DOI

Mazuski J.E., Solomkin J.S. Intra-abdominal infections. Surg. Clin. N. Am. 2009;89:421–437. doi: 10.1016/j.suc.2008.12.001. PubMed DOI

Eckmann C., Dryden M., Montravers P., Kozlov R., Sganga G. Antimicrobial treatment of “complicated” intra-abdominal infections and the new IDSA guidelines—A commentary and an alternative European approach according to clinical definitions. Eur. J. Med. Res. 2011;16:115–126. doi: 10.1186/2047-783X-16-3-115. PubMed DOI PMC

Li P.K.-T., Szeto C.C., Piraino B., De Arteaga J., Fan S., Figueiredo A.E., Fish D.N., Goffin E., Kim Y.-L., Salzer W., et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit. Dial. Int. J. Int. Soc. Perit. Dial. 2016;36:481–508. doi: 10.3747/pdi.2016.00078. PubMed DOI PMC

Gauzit R., Péan Y., Barth X., Mistretta F., Lalaude O., for the Top Study Team Epidemiology, Management, and Prognosis of Secondary Non-Postoperative Peritonitis: A French Prospective Observational Multicenter Study. Surg. Infect. 2009;10:119–127. doi: 10.1089/sur.2007.092. PubMed DOI

Heredia-Rodríguez M., Peláez M.T., Fierro I., Gómez-Sánchez E., Gómez-Pesquera E., Lorenzo M., Álvarez-González F.J., Bustamante-Munguira J., Eiros J.M., Bermejo-Martin J.F., et al. Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis. Ann. Intensiv. Care. 2016;6:34. doi: 10.1186/s13613-016-0137-5. PubMed DOI PMC

Koenig S.M., Truwit J.D. Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clin. Microbiol. Rev. 2006;19:637–657. doi: 10.1128/CMR.00051-05. PubMed DOI PMC

Uvizl R., Hanulik V., Husickova V., Sedlakova M.H., Adamus M., Kolar M. Hospital-acquired pneumonia in icu patients. Biomed. Pap. 2011;155:373–378. doi: 10.5507/bp.2011.067. PubMed DOI

American Thoracic Society and the Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005;171:388–416. doi: 10.1164/rccm.200405-644ST. PubMed DOI

Richardson J.D., DeCamp M.M., Garrison R.N., Fry D.E. Pulmonary infection complicating intra-abdominal sepsis: Clinical and experimental observations. Ann. Surg. 1982;195:732–738. doi: 10.1097/00000658-198206000-00009. PubMed DOI PMC

Mustard R.A., Bohnen J.M., Rosati C., Schouten B.D. Pneumonia complicating abdominal sepsis. An independent risk factor for mortality. Arch. Surg. 1991;126:170–175. doi: 10.1001/archsurg.1991.01410260058008. PubMed DOI

Thompson C., Makary M.A., Dorman T., Pronovost P.J. Clinical and Economic Outcomes of Hospital Acquired Pneumonia in Intra-Abdominal Surgery Patients. Ann. Surg. 2006;243:547–552. doi: 10.1097/01.sla.0000207097.38963.3b. PubMed DOI PMC

Kalil A.C., Metersky M.L., Klompas M., Muscedere J., Sweeney D.A., Palmer L.B., Napolitano L.M., O’Grady N.P., Bartlett J.G., Carratalà J., et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Inf. Dis. 2016;63:61–111. doi: 10.1093/cid/ciw353. PubMed DOI PMC

Torres A., Niederman M.S., Chastre J., Ewig S., Fernandez-Vandellos P., Hanberger H., Kollef M., Bassi G.L., Luna C.M., Martin-Loeches I., et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-Associated Pneumonia (VAP) of the European. Eur. Respir. J. 2017;50:1700582. doi: 10.1183/13993003.00582-2017. PubMed DOI

Herkel T., Uvizl R., Doubravská L., Adamus M., Gabrhelik T., Sedlakova M.H., Kolar M., Hanulik V., Pudova V., Langova K., et al. Epidemiology of hospital-acquired pneumonia: Results of a Central European multicenter, prospective, observational study compared with data from the European region. Biomed. Pap. 2016;160:448–455. doi: 10.5507/bp.2016.014. PubMed DOI

Pudová V., Working Group. Sedláková M.H., Kolář M. Clonality of Bacterial Pathogens Causing Hospital-Acquired Pneumonia. Curr. Microbiol. 2016;73:312–316. doi: 10.1007/s00284-016-1058-0. PubMed DOI

Luna C.M., Vujacich P., Niederman M.S., Vay C., Gherardi C., Matera J., Jolly E.C. Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia. Chest. 1997;111:676–685. doi: 10.1378/chest.111.3.676. PubMed DOI

Jang K.-S., Kim Y.H. Rapid and robust MALDI-TOF MS techniques for microbial identification: A brief overview of their diverse applications. J. Microbiol. 2018;56:209–216. doi: 10.1007/s12275-018-7457-0. PubMed DOI

European Committee on Antimicrobial Susceptibility Testing. [(accessed on 10 February 2023)]. Available online: http://www.eucast.org.

Sedlakova M.H., Hanulik V., Chroma M., Hricova K., Kolar M., Latal T., Schaumann R., Rodloff A.C. Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Med. Sci. Monit. 2011;17:BR147–BR152. doi: 10.12659/MSM.881761. PubMed DOI PMC

Dallenne C., Da Costa A., Decré D., Favier C., Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 2010;65:490–495. doi: 10.1093/jac/dkp498. PubMed DOI

Mlynarcik P., Dolejska M., Vagnerova I., Kutilová I., Kolar M. Detection of clinically important β-lactamases by using PCR. FEMS Microbiol. Lett. 2021;368:fnab068. doi: 10.1093/femsle/fnab068. PubMed DOI

Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002;40:2153–2162. doi: 10.1128/JCM.40.6.2153-2162.2002. PubMed DOI PMC

Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 1995;33:24–27. doi: 10.1128/jcm.33.1.24-27.1995. PubMed DOI PMC

Magiorakos A.-P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. PubMed DOI

Husickova V., Cekanova L., Chroma M., Htoutou-Sedlakova M., Hricova K., Kolar M. Carriage of ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tract of community subjects and hospitalized patients in the Czech Republic. Biomed. Pap. 2012;156:348–353. doi: 10.5507/bp.2012.039. PubMed DOI

Zakaria A.M., Hassuna N.A. Modified PFGE protocol for improving typeability of DNA degradation susceptible nosocomial Klebsiella pneumoniae. J. Med. Microbiol. 2019;68:1787–1792. doi: 10.1099/jmm.0.001093. PubMed DOI

Špička P., Chudáček J., Řezáč T., Starý L., Horáček R., Klos D. Prognostic significance of simple scoring systems in the prediction of diffuse peritonitis morbidity and mortality. Life. 2022;12:487. doi: 10.3390/life12040487. PubMed DOI PMC

Boeck L., Eggimann P., Smyrnios N., Pargger H., Thakkar N., Siegemund M., Morgenthaler N.G., Rakic J., Tamm M., Stolz D. The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia. J. Crit. Care. 2012;27:523.e1–523.e9. doi: 10.1016/j.jcrc.2011.07.081. PubMed DOI

Riché F.C., Dray X., Laisné M.-J., Matéo J., Raskine L., Pors M.-J.S.-L., Payen D., Valleur P., Cholley B.P. Factors associated with septic shock and mortality in generalized peritonitis: Comparison between community-acquired and postoperative peritonitis. Crit. Care. 2009;13:R99. doi: 10.1186/cc7931. PubMed DOI PMC

Inui T., Haridas M., Claridge J.A., Malangoni M.A. Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection. Surgery. 2009;146:654–662. doi: 10.1016/j.surg.2009.06.051. PubMed DOI

Kolář M. Bacterial Infections, Antimicrobial Resistance and Antibiotic Therapy. Life. 2022;12:468. doi: 10.3390/life12040468. PubMed DOI PMC